POLI, GUIDO
 Distribuzione geografica
Continente #
AS - Asia 4.997
EU - Europa 4.534
NA - Nord America 4.099
SA - Sud America 1.245
AF - Africa 115
OC - Oceania 8
Totale 14.998
Nazione #
US - Stati Uniti d'America 3.973
RU - Federazione Russa 2.603
SG - Singapore 1.789
CN - Cina 1.711
BR - Brasile 1.049
HK - Hong Kong 655
SE - Svezia 596
VN - Vietnam 413
RO - Romania 267
FR - Francia 263
IT - Italia 242
DE - Germania 165
GB - Regno Unito 92
IN - India 92
FI - Finlandia 83
AR - Argentina 71
BD - Bangladesh 57
IE - Irlanda 55
CA - Canada 54
MX - Messico 46
ID - Indonesia 43
EC - Ecuador 41
ZA - Sudafrica 39
IQ - Iraq 34
AT - Austria 31
TR - Turchia 31
NL - Olanda 30
PL - Polonia 27
JP - Giappone 26
ES - Italia 25
VE - Venezuela 19
MA - Marocco 18
UA - Ucraina 18
PY - Paraguay 17
PK - Pakistan 16
UZ - Uzbekistan 16
CO - Colombia 15
SA - Arabia Saudita 15
MY - Malesia 13
CL - Cile 11
EG - Egitto 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
DZ - Algeria 9
JM - Giamaica 9
PE - Perù 9
TW - Taiwan 9
UY - Uruguay 8
AU - Australia 7
IL - Israele 7
TN - Tunisia 7
KZ - Kazakistan 6
LT - Lituania 6
AL - Albania 5
IR - Iran 5
NP - Nepal 5
AM - Armenia 4
AZ - Azerbaigian 4
BO - Bolivia 4
CR - Costa Rica 4
GA - Gabon 4
NG - Nigeria 4
UG - Uganda 4
BE - Belgio 3
BG - Bulgaria 3
BY - Bielorussia 3
JO - Giordania 3
LB - Libano 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
KR - Corea 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
Totale 14.989
Città #
Dallas 1.485
Singapore 712
Hong Kong 651
Moscow 558
San Jose 526
Ashburn 448
Shanghai 267
Hefei 253
Lawrence 230
Princeton 230
Lauterbourg 219
Ho Chi Minh City 166
Beijing 108
New York 91
São Paulo 84
Hanoi 80
Los Angeles 71
Milan 67
Helsinki 61
Dublin 51
The Dalles 47
Nuremberg 37
Pune 34
Belo Horizonte 31
Boardman 30
Denver 30
Guangzhou 30
Munich 30
Washington 30
Santa Clara 29
Columbus 28
Brasília 27
Rio de Janeiro 27
Orem 26
Tokyo 26
Montreal 25
Haiphong 23
Warsaw 23
Seattle 21
Stockholm 21
Curitiba 20
Brooklyn 19
Chennai 19
Chicago 18
Frankfurt am Main 18
Houston 17
Poplar 17
Turku 17
Guayaquil 16
Rome 16
Shenzhen 16
Tashkent 16
Council Bluffs 15
Tianjin 15
Amsterdam 14
Johannesburg 14
Mexico City 14
Porto Alegre 14
Xi'an 14
London 13
Salvador 13
Dhaka 12
Baghdad 11
Jakarta 11
Kuala Lumpur 11
Ribeirão Preto 11
Vienna 11
Ankara 10
Atlanta 10
Boston 10
Campinas 10
Da Nang 10
Guarulhos 10
Biên Hòa 9
Buenos Aires 9
Cape Town 9
Caxias do Sul 9
Fortaleza 9
Hangzhou 9
Hải Dương 9
Joinville 9
Quito 9
Toronto 9
Zhengzhou 9
Charlotte 8
Fuzhou 8
Jeddah 8
Juiz de Fora 8
Kassel 8
Manaus 8
Manchester 8
Nairobi 8
Peschiera Borromeo 8
Cairo 7
Casablanca 7
Lima 7
Montevideo 7
Osasco 7
Santo André 7
Caruaru 6
Totale 7.614
Nome #
1,25-dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-Kappa B-independent enhancement of viral replication 1.433
Biobanking for COVID-19 research 144
Origin and evolution of SARS-CoV-2 141
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract 132
Modulation of NBAS-Related Functions in the Early Response to SARS-CoV-2 Infection 117
Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4) 115
ACTIVATED LYMPHOCYTES-B FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS INDUCE VIRUS EXPRESSION IN INFECTED T-CELLS AND A PROMONOCYTIC CELL-LINE, U1 113
Heparin Protects Human Neural Progenitor Cells from Zika Virus-Induced Cell Death While Preserving Their Differentiation into Mature Neuroglial Cells 109
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 109
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 107
A PLATELET-ACTIVATING-FACTOR ANTAGONIST, RP-55778, INHIBITS CYTOKINE-DEPENDENT INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION IN CHRONICALLY INFECTED PROMONOCYTIC CELLS 99
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity 99
Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimens 98
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. 98
Association between the presence of CCR5-specific antibodies and long term non progression 96
A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTIC CELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS 95
An approach to HIV gene therapy by transduction of multifunctional retroviral vectors in primary human T Lymphocytes 94
Candidate Microbicide 5-hydroxytyrosol (5-HT) Inhibits Productive R5 HIV-1 Infection of Human Cervical Tissue Explants (CTE). 93
A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1 93
Restriction of Zika Virus Replication in Human Monocyte-Derived Macrophages by Pro-Inflammatory (M1) Polarization 92
In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. 92
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 91
[Transitory increase of OKT4+ lymphocytes in the peripheral blood of patients with lymphadenopathy syndrome treated with beta-interferon]. FT Incremento transitorio dei linfociti OKT4+ in sangue periferico di pazienti affetti da LAS trattati con IFN-beta. 88
ALPHA-INTERFERON SUPPRESSES VIRION BUT NOT SOLUBLE HUMAN-IMMUNODEFICIENCY-VIRUS ANTIGEN PRODUCTION IN CHRONICALLY INFECTED T-LYMPHOCYTIC CELLS 88
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 87
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls 84
Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load (Nature, (2023), 620, 7976, (1025-1030), 10.1038/s41586-023-06370-4) 83
The Long and Winding Road towards an HIV Cure 82
Amotosalen Photochemical Inactivation of Severe Acute Respiratory Syndrome CoronaVirus (SARS-CoV) in Human Platelet Concentrates 78
Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells 77
Africa-specific human genetic variation near CHD1L associates with HIV-1 load 76
Asymmetric HIV-1 co-receptor use and replication in CD4+ T lymphocytes 76
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. 75
Preface 72
Coronaviridae and SARS-associated coronavirus strain HSR1 72
Retroviruses and opportunistic infections--eighth annual conference--structured therapy interruption. 71
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines 71
Preface 70
Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer 70
Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus 70
Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells 69
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy 68
TRIM22. A multitasking antiviral factor 68
Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4+T lymphocytes, a transcriptome analysis 67
Erratum: Correction for Kajaste-Rudnitski et al., "TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-κB-Responsive Long Terminal Repeat Elements" (Journal of virology (2011) 85 10 DOI: 10.1128/JVI.02302-10.) 66
M1 and M2a Polarization of Human Monocyte-Derived Macrophages Inhibits HIV-1 Replication by Distinct Mechanisms 66
Zika Virus: a re-emerging pathogen with rapidly evolving public health implications 66
INTERFERON-GAMMA INDUCES THE EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERSISTENTLY INFECTED PROMONOCYTIC CELLS (U1) AND REDIRECTS THE PRODUCTION OF VIRIONS TO INTRACYTOPLASMIC VACUOLES IN PHORBOL-MYRISTATE ACETATE DIFFERENTIATED U1 CELLS 65
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo 65
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. 64
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication 64
IMMUNOPATHOGENIC MECHANISMS IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION 64
INTERFERONS IN THE PATHOGENESIS AND TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION 63
Engagement of CD30 shapes the secretion of cytokines by human gamma delta T cells 63
Mononuclear phagocytes and HIV infection 63
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease 62
Laureate ESCI award for excellence in clinical science 1999: cytokines and the human immunodeficiency virus: from bench to bedside 62
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands 62
Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral Latency 61
FP-21399 (Lexigen Pharmaceuticals). 61
PRO-140 (Progenics). 61
Restricted replication of non-syncytium-inducing HIV in Th1 and Th2 lymphocytes 61
Human Monocyte-Derived Macrophages (MDM): Model 2 60
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection 60
Bacterial toxins: Potential weapons against HIV infection 60
Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1CD4(+) T cells 60
Long-lasting CCR5 internalization by antibodies in a subset of long-term non progressors: a possible protective effect against disease progression 60
The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages 59
Preparing for phase II/III HIV vaccine trials in Africa 59
The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection 59
Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives 59
Cytokine modulation of HIV expression. 59
Vaccine adjuvants: A priority for vaccine research 59
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat 59
Macrophage polarization and HIV-1 infection 58
Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation 58
RECOMBINANT GP120 SPECIFICALLY ENHANCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND IG SECRETION IN LYMPHOCYTES-B FROM HIV-INFECTED INDIVIDUALS BUT NOT FROM SERONEGATIVE DONORS 58
Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection 58
Chronically infected T-cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1 58
Role of cytokines and chemokines in the regulation of innate immunity and HIV infection 57
HIV REPLICATION IN IL-2-STIMULATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS IS DRIVEN IN AN AUTOCRINE PARACRINE MANNER BY ENDOGENOUS CYTOKINES 57
Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells 57
ULTRAVIOLET-IRRADIATION AND CYTOKINES AS REGULATORS OF HIV LATENCY AND EXPRESSION 56
THE ROLE OF MONOCYTE MACROPHAGES AND CYTOKINES IN THE PATHOGENESIS OF HIV-INFECTION 56
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells 56
MCP-1 and CCR2 in HIV infection: Regulation of agonist and receptor expression 55
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein 55
INTERLEUKIN-1 INDUCES EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ALONE AND IN SYNERGY WITH INTERLEUKIN-6 IN CHRONICALLY INFECTED U1 CELLS - INHIBITION OF INDUCTIVE EFFECTS BY THE INTERLEUKIN-1 RECEPTOR ANTAGONIST 55
N-acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently infected cells. 55
Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection 54
Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine 54
Unsung Hero Robert C. Gallo 54
THE EFFECT OF CYTOKINES AND PHARMACOLOGICAL AGENTS ON CHRONIC HIV-INFECTION 54
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT. 54
IMMUNOPATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION 53
Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome 53
Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type I-infected individuals receiving intermittent cycles of interleukin 2 53
Impairment of in vitro natural antibacterial activity in HIV-infected patients 53
CYTOKINE REGULATION OF ACUTE AND CHRONIC HIV-INFECTION IN-VITRO - FROM CELL-LINES TO PRIMARY MONONUCLEAR-CELLS 52
Immunologic reconstitution by interleukin-2: facts and open questions 52
Totale 8.609
Categoria #
all - tutte 96.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022110 0 0 0 59 16 3 4 5 1 3 3 16
2022/20231.174 542 237 95 8 10 108 56 57 25 4 27 5
2023/2024480 7 26 63 25 35 136 22 38 4 28 28 68
2024/20253.332 385 44 64 90 80 266 640 232 525 533 239 234
2025/20269.964 702 1.066 1.534 1.348 550 250 965 704 2.416 429 0 0
Totale 15.100